Document QXnavp6VzJ2w9d63Eoad2NYJL

To: From: Cc: Bcc: Received Date: Subject: Steup, David R Alliance <lO=SHELLlOU=MSXSSC/CN=PARTCOMP/CN=EQUILONlCN =DRSTEUPEQ> Mallett, Anthony AK SC-CHSE-TM <lO=SHELLlOU=OPC/CN=RECIPI ENTS/CN=WYAMJD> Cagen, Stuart SZ SCC <lO=SHELLlOU=MSXSCC/CN=RECI PI ENTS/CN=SC724012>; David Owen <lO=SHELLlOU=OPC/CN=RECIPI ENTS/CN=SNDOW4>; Patsy Hill <lO=SHELLlOU=MSXSOPC/CN=RECIPI ENTS/CN=PH197432> ; Robert Priston <lO=SHELLlOU=OPC/CN=RECIPIENTS/CN=SNRPR1> 2000-06-0218:22:54 GMT API I benzene proposal David, fyi some breaking news with respect to the Shanghai proposal. This has now also been raised by Exxon as an item for general discussion within the CEFIC Aromatic's Sector Group, and at least one EU representative (Chris Roythorne Medical Director, BP Amoco) has been invited to attend (and plans to go, apparently). The message is reaching a larger audience even as we speak ..... Regards Tony Mallett, HSE Toxicology Adviser and Product Steward - Aromatics, London Shell Chemicals Limited CHSE-TM Shell Centre York Road London, SE1 7NA Tel: +44 (0)207 934 2392 Fax: +44 (0)207 934 7627 E-mail: anthony.k.mallett@opc.shell.com Tony Mallett, HSE Toxicology Adviser and Product Steward - Aromatics, London Shell Chemicals Limited CHSE-TM Shell Centre York Road London, SE1 7NA Tel: +44 (0)207 934 2392 Fax: +44 (0)207 934 7627 E-mail: anthony.k.mallett@opc.shell.com SH ELL-MCCLU RG-055050